-
Deidentified Individual Participant Data Set (IPD)
-
Yes - There is a plan to make this available
-
Study Protocol
-
Yes - There is a plan to make this available
-
Statistical Analysis Plan
-
Yes - There is a plan to make this available
-
Informed Consent Form
-
Yes - There is a plan to make this available
-
Clinical Study Report
-
Yes - There is a plan to make this available
-
Analytic Code
-
Yes - There is a plan to make this available
-
Data Dictionary
-
Yes - There is a plan to make this available
-
Title and more details about the data/document
-
The individual participant data (IPD) will include de-identified baseline patient characteristics, neurosurgical diagnoses and procedure-related information, treatment allocation, intraoperative blood-loss variables, and the prespecified efficacy and safety outcomes, including total blood loss, postoperative rebleeding, surgical site infection, venous gas embolism, postoperative pneumocephalus, and trigeminocardiac reflex. De-identified data from all 96 randomized participants will be made available, subject to applicable ethical and confidentiality requirements.
The following supporting documents will also be shared: the final study protocol and its amendments, the statistical analysis plan (SAP), a blank and unsigned version of the informed consent form, the final clinical study report containing aggregated results, statistical analysis codes developed using R and SPSS (if generated), and the study data dictionary.
All direct and indirect personal identifiers will be removed or appropriately modified before data sharing. No identifiable medical records or signed participant consent forms will be disclosed.
-
When the data will become available and for how long
-
The final study protocol and amendments, statistical analysis plan, blank informed consent form, data dictionary, statistical analysis codes, and final clinical study report will be made available upon publication of the primary study results.
De-identified individual participant data and accompanying metadata will become available six months after publication of the primary study results and will remain accessible for at least five years thereafter. Data access will be subject to the necessary ethical and institutional approvals and execution of a data use agreement, where applicable.
-
To whom data/document is available
-
Qualified researchers affiliated with universities, research centers, medical institutions, or other recognized research organizations may request access to the study data and supporting documents, regardless of their country of residence. Requests from independent researchers or individuals affiliated with non-academic institutions may also be considered, provided that they demonstrate appropriate scientific qualifications and comply with ethical and confidentiality requirements. All requests will be reviewed by the principal investigator and the research team before approval.
-
Under which criteria data/document could be used
-
The shared data and documents may be used exclusively for scientifically valid research purposes, including secondary analyses, validation of study findings, replication of results, comparative research, additional investigations, and systematic reviews and meta-analyses.
Applicants must provide their research objectives, research questions or hypotheses, proposed methodology, and statistical analysis plan. Approval from the relevant ethics committee and execution of a data use agreement may be required, as applicable.
Any attempt to re-identify participants, link the dataset to identifiable personal information, transfer the data to unauthorized third parties, or use the data for purposes beyond the approved research objectives is strictly prohibited. All recipients must maintain data confidentiality and security and appropriately acknowledge and cite the original study in any resulting publications.
-
From where data/document is obtainable
-
Formal data access requests should be submitted by email to Dr. Farhad Mirzaei, First Academic Supervisor and Scientific Lead of the Study, Department of Neurosurgery, Faculty of Medicine, Tabriz University of Medical Sciences, Imam Reza Hospital, Tabriz, Iran.
Email: golzar.farhad@yahoo.com
Each request should include the applicant's details, institutional affiliation, research objectives, and relevant supporting scientific documents. All requests will be reviewed by the research team, and the decision will be communicated to the applicant.
-
What processes are involved for a request to access data/document
-
Upon receipt of a request, the research team will assess the applicant's scientific qualifications, institutional affiliation, research objectives, and the compatibility of the proposed project with ethical requirements and data use conditions.
Applicants must provide a brief description of their research question, proposed analytical methods, requested variables, and, where applicable, approval from their institutional ethics committee. Following approval, a data use agreement must be completed and signed.
An initial response will be provided within 30 working days after receipt of a complete application. Upon approval and completion of all applicable ethical and administrative requirements, the requested data and documents will be provided through a secure data transfer method within an additional 30 working days. Incomplete requests or requests that do not comply with ethical and confidentiality requirements may be declined.
-
Comments
-
Data and document sharing will be conducted to promote research transparency, reproducibility of findings, and further scientific investigations. All datasets will undergo appropriate de-identification and disclosure risk assessment before being shared. Access will be provided exclusively through a controlled access mechanism in compliance with ethics committee approvals and the regulations of Tabriz University of Medical Sciences. Recipients will be responsible for maintaining confidentiality and ensuring appropriate use of the shared data.